25 XP   0   0   10

Pacific Shuanglin Bio pharmacy Co Ltd
Buy, Hold or Sell?

Let's analyse Pacific Shuanglin Bio pharmacy Co Ltd together

PenkeI guess you are interested in Pacific Shuanglin Bio pharmacy Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Pacific Shuanglin Bio pharmacy Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Pacific Shuanglin Bio pharmacy Co Ltd

I send you an email if I find something interesting about Pacific Shuanglin Bio pharmacy Co Ltd.

Quick analysis of Pacific Shuanglin Bio pharmacy Co Ltd (30 sec.)










What can you expect buying and holding a share of Pacific Shuanglin Bio pharmacy Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.04
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥9.36
Expected worth in 1 year
¥12.28
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥3.19
Return On Investment
10.8%

For what price can you sell your share?

Current Price per Share
¥29.63
Expected price per share
¥27.88 - ¥31.25
How sure are you?
50%

1. Valuation of Pacific Shuanglin Bio pharmacy Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥29.63

Intrinsic Value Per Share

¥0.38 - ¥4.19

Total Value Per Share

¥9.74 - ¥13.56

2. Growth of Pacific Shuanglin Bio pharmacy Co Ltd (5 min.)




Is Pacific Shuanglin Bio pharmacy Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$947.5m$873.8m$73.6m7.8%

How much money is Pacific Shuanglin Bio pharmacy Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$81m$54m$27m33.4%
Net Profit Margin24.4%19.8%--

How much money comes from the company's main activities?

3. Financial Health of Pacific Shuanglin Bio pharmacy Co Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

What can you expect buying and holding a share of Pacific Shuanglin Bio pharmacy Co Ltd? (5 min.)

Welcome investor! Pacific Shuanglin Bio pharmacy Co Ltd's management wants to use your money to grow the business. In return you get a share of Pacific Shuanglin Bio pharmacy Co Ltd.

What can you expect buying and holding a share of Pacific Shuanglin Bio pharmacy Co Ltd?

First you should know what it really means to hold a share of Pacific Shuanglin Bio pharmacy Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Pacific Shuanglin Bio pharmacy Co Ltd is ¥29.63. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pacific Shuanglin Bio pharmacy Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pacific Shuanglin Bio pharmacy Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥9.36. Based on the TTM, the Book Value Change Per Share is ¥0.73 per quarter. Based on the YOY, the Book Value Change Per Share is ¥7.31 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.07 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pacific Shuanglin Bio pharmacy Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.110.4%0.110.4%0.070.2%0.050.2%0.030.1%
Usd Book Value Change Per Share0.100.3%0.100.3%1.013.4%0.240.8%0.120.4%
Usd Dividend Per Share0.010.0%0.010.0%0.000.0%0.020.1%0.010.0%
Usd Total Gains Per Share0.110.4%0.110.4%1.013.4%0.250.9%0.130.4%
Usd Price Per Share3.14-3.14-3.87-4.18-3.97-
Price to Earnings Ratio28.40-28.40-52.53-128.43-285.75-
Price-to-Total Gains Ratio28.53-28.53-3.82-86.29-219.41-
Price to Book Ratio2.43-2.43-3.25-19.80-30.03-
Price-to-Total Gains Ratio28.53-28.53-3.82-86.29-219.41-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.091903
Number of shares244
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.02
Usd Book Value Change Per Share0.100.24
Usd Total Gains Per Share0.110.25
Gains per Quarter (244 shares)26.8861.72
Gains per Year (244 shares)107.53246.88
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
19989815232237
21819720630464484
32729531445696731
43739442260927978
5464925307511591225
6555906389013911472
76468974610516231719
87378785412018551966
98288696213520872213
1091984107015023192460

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.00.04.081.8%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.04.00.081.8%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%22.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.04.00.081.8%

Fundamentals of Pacific Shuanglin Bio pharmacy Co Ltd

About Pacific Shuanglin Bio pharmacy Co Ltd

Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in research, development, production, and sales of blood products in China. Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), hepatitis B human immunoglobulin, tetanus human immunoglobulin, rabies patient immunoglobulin, and human coagulation factor. addition, it engages in the investment, consultation, and technology promotion of pharmaceutical and biotechnology development projects; and electronic product information consultation. The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021. Pacific Shuanglin Bio-pharmacy Co., Ltd. was founded in 1993 and is based in Taiyuan, China.

Fundamental data was last updated by Penke on 2024-04-13 16:04:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Pacific Shuanglin Bio pharmacy Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pacific Shuanglin Bio pharmacy Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Pacific Shuanglin Bio pharmacy Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 24.4% means that ¥0.24 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pacific Shuanglin Bio pharmacy Co Ltd:

  • The MRQ is 24.4%. The company is making a huge profit. +2
  • The TTM is 24.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ24.4%TTM24.4%0.0%
TTM24.4%YOY19.8%+4.6%
TTM24.4%5Y17.8%+6.7%
5Y17.8%10Y15.9%+1.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ24.4%-196.1%+220.5%
TTM24.4%-211.9%+236.3%
YOY19.8%-277.7%+297.5%
5Y17.8%-432.9%+450.7%
10Y15.9%-599.3%+615.2%
1.1.2. Return on Assets

Shows how efficient Pacific Shuanglin Bio pharmacy Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pacific Shuanglin Bio pharmacy Co Ltd to the Biotechnology industry mean.
  • 7.4% Return on Assets means that Pacific Shuanglin Bio pharmacy Co Ltd generated ¥0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pacific Shuanglin Bio pharmacy Co Ltd:

  • The MRQ is 7.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 7.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ7.4%TTM7.4%0.0%
TTM7.4%YOY5.5%+1.8%
TTM7.4%5Y8.6%-1.2%
5Y8.6%10Y7.2%+1.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.4%-13.3%+20.7%
TTM7.4%-12.7%+20.1%
YOY5.5%-11.8%+17.3%
5Y8.6%-14.0%+22.6%
10Y7.2%-15.9%+23.1%
1.1.3. Return on Equity

Shows how efficient Pacific Shuanglin Bio pharmacy Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pacific Shuanglin Bio pharmacy Co Ltd to the Biotechnology industry mean.
  • 8.5% Return on Equity means Pacific Shuanglin Bio pharmacy Co Ltd generated ¥0.09 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pacific Shuanglin Bio pharmacy Co Ltd:

  • The MRQ is 8.5%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 8.5%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ8.5%TTM8.5%0.0%
TTM8.5%YOY6.2%+2.4%
TTM8.5%5Y13.3%-4.8%
5Y13.3%10Y15.1%-1.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.5%-16.9%+25.4%
TTM8.5%-16.0%+24.5%
YOY6.2%-15.1%+21.3%
5Y13.3%-19.7%+33.0%
10Y15.1%-20.5%+35.6%

1.2. Operating Efficiency of Pacific Shuanglin Bio pharmacy Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pacific Shuanglin Bio pharmacy Co Ltd is operating .

  • Measures how much profit Pacific Shuanglin Bio pharmacy Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pacific Shuanglin Bio pharmacy Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 25.4% means the company generated ¥0.25  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pacific Shuanglin Bio pharmacy Co Ltd:

  • The MRQ is 25.4%. The company is operating very efficient. +2
  • The TTM is 25.4%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ25.4%TTM25.4%0.0%
TTM25.4%YOY22.8%+2.6%
TTM25.4%5Y20.9%+4.6%
5Y20.9%10Y16.6%+4.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ25.4%-290.9%+316.3%
TTM25.4%-224.4%+249.8%
YOY22.8%-288.3%+311.1%
5Y20.9%-479.5%+500.4%
10Y16.6%-625.2%+641.8%
1.2.2. Operating Ratio

Measures how efficient Pacific Shuanglin Bio pharmacy Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.22 means that the operating costs are ¥1.22 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Pacific Shuanglin Bio pharmacy Co Ltd:

  • The MRQ is 1.225. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.225. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.225TTM1.2250.000
TTM1.225YOY1.311-0.087
TTM1.2255Y1.282-0.057
5Y1.28210Y1.093+0.189
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2253.110-1.885
TTM1.2253.266-2.041
YOY1.3113.783-2.472
5Y1.2825.657-4.375
10Y1.0937.783-6.690

1.3. Liquidity of Pacific Shuanglin Bio pharmacy Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pacific Shuanglin Bio pharmacy Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.18 means the company has ¥3.18 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Pacific Shuanglin Bio pharmacy Co Ltd:

  • The MRQ is 3.176. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.176. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.176TTM3.1760.000
TTM3.176YOY3.845-0.668
TTM3.1765Y2.255+0.921
5Y2.25510Y1.376+0.878
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1763.905-0.729
TTM3.1764.212-1.036
YOY3.8455.337-1.492
5Y2.2556.062-3.807
10Y1.3766.401-5.025
1.3.2. Quick Ratio

Measures if Pacific Shuanglin Bio pharmacy Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pacific Shuanglin Bio pharmacy Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 1.31 means the company can pay off ¥1.31 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pacific Shuanglin Bio pharmacy Co Ltd:

  • The MRQ is 1.312. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.312. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.312TTM1.3120.000
TTM1.312YOY1.289+0.022
TTM1.3125Y0.797+0.514
5Y0.79710Y0.448+0.349
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3123.572-2.260
TTM1.3124.001-2.689
YOY1.2895.364-4.075
5Y0.7976.009-5.212
10Y0.4486.287-5.839

1.4. Solvency of Pacific Shuanglin Bio pharmacy Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pacific Shuanglin Bio pharmacy Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pacific Shuanglin Bio pharmacy Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.14 means that Pacific Shuanglin Bio pharmacy Co Ltd assets are financed with 14.0% credit (debt) and the remaining percentage (100% - 14.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pacific Shuanglin Bio pharmacy Co Ltd:

  • The MRQ is 0.140. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.140. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.140TTM0.1400.000
TTM0.140YOY0.107+0.033
TTM0.1405Y0.312-0.172
5Y0.31210Y0.460-0.148
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1400.336-0.196
TTM0.1400.334-0.194
YOY0.1070.271-0.164
5Y0.3120.366-0.054
10Y0.4600.389+0.071
1.4.2. Debt to Equity Ratio

Measures if Pacific Shuanglin Bio pharmacy Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pacific Shuanglin Bio pharmacy Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 16.3% means that company has ¥0.16 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pacific Shuanglin Bio pharmacy Co Ltd:

  • The MRQ is 0.163. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.163. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.163TTM0.1630.000
TTM0.163YOY0.120+0.043
TTM0.1635Y0.535-0.372
5Y0.53510Y1.126-0.591
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1630.382-0.219
TTM0.1630.397-0.234
YOY0.1200.341-0.221
5Y0.5350.432+0.103
10Y1.1260.465+0.661

2. Market Valuation of Pacific Shuanglin Bio pharmacy Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Pacific Shuanglin Bio pharmacy Co Ltd generates.

  • Above 15 is considered overpriced but always compare Pacific Shuanglin Bio pharmacy Co Ltd to the Biotechnology industry mean.
  • A PE ratio of 28.40 means the investor is paying ¥28.40 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pacific Shuanglin Bio pharmacy Co Ltd:

  • The EOD is 36.978. Based on the earnings, the company is overpriced. -1
  • The MRQ is 28.405. Based on the earnings, the company is overpriced. -1
  • The TTM is 28.405. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD36.978MRQ28.405+8.574
MRQ28.405TTM28.4050.000
TTM28.405YOY52.533-24.128
TTM28.4055Y128.426-100.022
5Y128.42610Y285.747-157.321
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD36.978-2.262+39.240
MRQ28.405-2.599+31.004
TTM28.405-2.674+31.079
YOY52.533-4.133+56.666
5Y128.426-6.258+134.684
10Y285.747-6.171+291.918
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pacific Shuanglin Bio pharmacy Co Ltd:

  • The EOD is 149.138. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 114.559. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 114.559. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD149.138MRQ114.559+34.579
MRQ114.559TTM114.5590.000
TTM114.559YOY250.351-135.792
TTM114.5595Y192.576-78.017
5Y192.57610Y425.188-232.612
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD149.138-2.913+152.051
MRQ114.559-3.275+117.834
TTM114.559-3.508+118.067
YOY250.351-5.620+255.971
5Y192.576-8.306+200.882
10Y425.188-8.854+434.042
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pacific Shuanglin Bio pharmacy Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.43 means the investor is paying ¥2.43 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Pacific Shuanglin Bio pharmacy Co Ltd:

  • The EOD is 3.164. Based on the equity, the company is fair priced.
  • The MRQ is 2.431. Based on the equity, the company is underpriced. +1
  • The TTM is 2.431. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.164MRQ2.431+0.734
MRQ2.431TTM2.4310.000
TTM2.431YOY3.247-0.816
TTM2.4315Y19.800-17.370
5Y19.80010Y30.032-10.232
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.1641.858+1.306
MRQ2.4312.090+0.341
TTM2.4312.091+0.340
YOY3.2472.866+0.381
5Y19.8003.488+16.312
10Y30.0323.836+26.196
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Pacific Shuanglin Bio pharmacy Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.7300.7300%7.314-90%1.720-58%0.897-19%
Book Value Per Share--9.3649.3640%8.634+8%4.251+120%2.459+281%
Current Ratio--3.1763.1760%3.845-17%2.255+41%1.376+131%
Debt To Asset Ratio--0.1400.1400%0.107+31%0.312-55%0.460-69%
Debt To Equity Ratio--0.1630.1630%0.120+36%0.535-69%1.126-86%
Dividend Per Share--0.0680.0680%0.016+312%0.111-39%0.0680%
Eps--0.8010.8010%0.534+50%0.383+109%0.238+236%
Free Cash Flow Per Share--0.1990.1990%0.112+77%0.167+19%0.061+226%
Free Cash Flow To Equity Per Share--0.4010.4010%1.553-74%0.448-10%0.194+107%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--4.193--------
Intrinsic Value_10Y_min--0.379--------
Intrinsic Value_1Y_max--0.227--------
Intrinsic Value_1Y_min--0.056--------
Intrinsic Value_3Y_max--0.830--------
Intrinsic Value_3Y_min--0.153--------
Intrinsic Value_5Y_max--1.610--------
Intrinsic Value_5Y_min--0.234--------
Market Cap21711204720.000+23%16677253440.00016677253440.0000%20543726129.020-19%22177831238.924-25%21085983816.982-21%
Net Profit Margin--0.2440.2440%0.198+23%0.178+37%0.159+53%
Operating Margin--0.2540.2540%0.228+11%0.209+22%0.166+53%
Operating Ratio--1.2251.2250%1.311-7%1.282-4%1.093+12%
Pb Ratio3.164+23%2.4312.4310%3.247-25%19.800-88%30.032-92%
Pe Ratio36.978+23%28.40528.4050%52.533-46%128.426-78%285.747-90%
Price Per Share29.630+23%22.76022.7600%28.030-19%30.265-25%28.776-21%
Price To Free Cash Flow Ratio149.138+23%114.559114.5590%250.351-54%192.576-41%425.188-73%
Price To Total Gains Ratio37.140+23%28.52928.5290%3.824+646%86.285-67%219.413-87%
Quick Ratio--1.3121.3120%1.289+2%0.797+65%0.448+192%
Return On Assets--0.0740.0740%0.055+33%0.086-14%0.072+2%
Return On Equity--0.0850.0850%0.062+38%0.133-36%0.151-43%
Total Gains Per Share--0.7980.7980%7.330-89%1.832-56%0.965-17%
Usd Book Value--947521671.308947521671.3080%873859587.084+8%430232510.165+120%248835020.389+281%
Usd Book Value Change Per Share--0.1010.1010%1.010-90%0.238-58%0.124-19%
Usd Book Value Per Share--1.2931.2930%1.192+8%0.587+120%0.340+281%
Usd Dividend Per Share--0.0090.0090%0.002+312%0.015-39%0.0090%
Usd Eps--0.1110.1110%0.074+50%0.053+109%0.033+236%
Usd Free Cash Flow--20104309.06420104309.0640%11332452.020+77%16948827.786+19%6176336.806+226%
Usd Free Cash Flow Per Share--0.0270.0270%0.015+77%0.023+19%0.008+226%
Usd Free Cash Flow To Equity Per Share--0.0550.0550%0.214-74%0.062-10%0.027+107%
Usd Market Cap2998317371.832+23%2303128700.0642303128700.0640%2837088578.418-19%3062758494.095-25%2911974365.125-21%
Usd Price Per Share4.092+23%3.1433.1430%3.871-19%4.180-25%3.974-21%
Usd Profit--81082859.02681082859.0260%54005935.423+50%38794820.393+109%24404416.912+232%
Usd Revenue--332156521.544332156521.5440%272296509.019+22%198929191.646+67%136999897.332+142%
Usd Total Gains Per Share--0.1100.1100%1.012-89%0.253-56%0.133-17%
 EOD+4 -4MRQTTM+0 -0YOY+23 -125Y+21 -1410Y+23 -12

3.2. Fundamental Score

Let's check the fundamental score of Pacific Shuanglin Bio pharmacy Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1536.978
Price to Book Ratio (EOD)Between0-13.164
Net Profit Margin (MRQ)Greater than00.244
Operating Margin (MRQ)Greater than00.254
Quick Ratio (MRQ)Greater than11.312
Current Ratio (MRQ)Greater than13.176
Debt to Asset Ratio (MRQ)Less than10.140
Debt to Equity Ratio (MRQ)Less than10.163
Return on Equity (MRQ)Greater than0.150.085
Return on Assets (MRQ)Greater than0.050.074
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Pacific Shuanglin Bio pharmacy Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose30.000
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets7,982,324
Total Liabilities1,121,197
Total Stockholder Equity6,867,524
 As reported
Total Liabilities 1,121,197
Total Stockholder Equity+ 6,867,524
Total Assets = 7,982,324

Assets

Total Assets7,982,324
Total Current Assets3,046,976
Long-term Assets4,935,349
Total Current Assets
Cash And Cash Equivalents 1,000,797
Short-term Investments 422,435
Net Receivables 835,877
Inventory 623,689
Other Current Assets 59,260
Total Current Assets  (as reported)3,046,976
Total Current Assets  (calculated)2,942,058
+/- 104,917
Long-term Assets
Property Plant Equipment 1,296,621
Goodwill 2,614,612
Intangible Assets 272,543
Other Assets 831,601
Long-term Assets  (as reported)4,935,349
Long-term Assets  (calculated)5,015,376
+/- 80,028

Liabilities & Shareholders' Equity

Total Current Liabilities959,309
Long-term Liabilities161,888
Total Stockholder Equity6,867,524
Total Current Liabilities
Short Long Term Debt 275,102
Accounts payable 158,370
Other Current Liabilities 454,013
Total Current Liabilities  (as reported)959,309
Total Current Liabilities  (calculated)887,484
+/- 71,825
Long-term Liabilities
Other Liabilities 79,408
Deferred Long Term Liability 89,701
Long-term Liabilities  (as reported)161,888
Long-term Liabilities  (calculated)169,109
+/- 7,221
Total Stockholder Equity
Common Stock732,387
Retained Earnings 1,392,311
Other Stockholders Equity 36
Total Stockholder Equity (as reported)6,867,524
Total Stockholder Equity (calculated)2,124,733
+/- 4,742,791
Other
Capital Stock732,387
Common Stock Shares Outstanding 732,387
Net Invested Capital 7,195,512
Net Tangible Assets 4,060,397
Net Working Capital 2,087,667
Property Plant and Equipment Gross 1,296,621



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
1,178,575
1,378,647
1,544,548
2,241,031
2,115,632
2,082,555
1,705,459
1,659,493
1,214,775
1,251,795
925,414
960,805
1,067,946
1,187,156
1,193,806
1,265,309
1,243,318
1,320,580
1,317,557
1,271,642
1,652,617
7,087,798
7,982,324
7,982,3247,087,7981,652,6171,271,6421,317,5571,320,5801,243,3181,265,3091,193,8061,187,1561,067,946960,805925,4141,251,7951,214,7751,659,4931,705,4592,082,5552,115,6322,241,0311,544,5481,378,6471,178,575
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
407,137
619,432
689,246
755,229
778,925
872,713
2,469,327
3,046,976
3,046,9762,469,327872,713778,925755,229689,246619,432407,137000000000000000
       Cash And Cash Equivalents 
173,440
260,300
357,900
268,585
38,025
27,989
18,740
23,150
8,267
61,754
15,008
52,551
37,922
16,029
43,697
51,639
202,823
145,872
154,767
110,943
102,827
885,673
1,000,797
1,000,797885,673102,827110,943154,767145,872202,82351,63943,69716,02937,92252,55115,00861,7548,26723,15018,74027,98938,025268,585357,900260,300173,440
       Short-term Investments 
0
0
1,388
11,905
2,052
716
566
1,685
28
47
50
0
0
0
0
0
0
5,000
0
0
0
234,208
422,435
422,435234,2080005,0000000005047281,6855667162,05211,9051,38800
       Net Receivables 
353,963
361,285
281,420
411,300
619,471
357,528
221,545
261,121
65,511
52,983
39,189
155,197
42,133
28,838
32,070
39,900
97,528
138,352
202,631
258,080
319,925
593,946
835,877
835,877593,946319,925258,080202,631138,35297,52839,90032,07028,83842,133155,19739,18952,98365,511261,121221,545357,528619,471411,300281,420361,285353,963
       Other Current Assets 
93,932
61,421
65,020
107,316
48,517
68,980
62,841
47,370
13,223
26,302
18,560
34,441
9,317
28,397
28,128
47,970
11,696
20,544
7,939
5,219
6,440
16,532
59,260
59,26016,5326,4405,2197,93920,54411,69647,97028,12828,3979,31734,44118,56026,30213,22347,37062,84168,98048,517107,31665,02061,42193,932
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
650,734
631,334
564,759
492,717
779,074
4,618,471
4,935,349
4,935,3494,618,471779,074492,717564,759631,334650,7340000000000000000
       Property Plant Equipment 
288,776
319,083
383,411
643,077
633,714
1,273,219
1,088,136
880,614
864,247
856,074
621,833
552,916
774,659
877,526
761,421
773,071
505,384
485,728
457,337
388,091
382,972
1,103,222
1,296,621
1,296,6211,103,222382,972388,091457,337485,728505,384773,071761,421877,526774,659552,916621,833856,074864,247880,6141,088,1361,273,219633,714643,077383,411319,083288,776
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,614,612
2,614,612
2,614,6122,614,612000000000000000000000
       Intangible Assets 
5,732
22,370
49,353
244,677
226,493
55,230
82,480
181,211
20,647
8,439
108,847
115,051
113,113
103,671
68,948
73,126
71,890
69,811
69,518
72,775
91,094
257,382
272,543
272,543257,38291,09472,77569,51869,81171,89073,12668,948103,671113,113115,051108,8478,43920,647181,21182,48055,230226,493244,67749,35322,3705,732
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
43,861
42,311
2,897
2,669
2,847
25,819
92,446
92,44625,8192,8472,6692,89742,31143,8610000000000000000
> Total Liabilities 
579,294
690,823
765,520
1,400,704
1,513,496
1,970,069
1,732,618
1,649,570
1,037,512
1,114,155
651,418
678,061
780,267
835,472
735,156
739,819
696,406
761,696
698,078
470,038
685,711
760,067
1,121,197
1,121,197760,067685,711470,038698,078761,696696,406739,819735,156835,472780,267678,061651,4181,114,1551,037,5121,649,5701,732,6181,970,0691,513,4961,400,704765,520690,823579,294
   > Total Current Liabilities 
461,972
645,451
740,240
1,184,374
1,401,786
1,697,379
1,546,708
1,591,158
975,868
1,050,593
618,694
657,061
758,667
721,472
612,465
667,482
691,137
700,325
667,793
440,058
645,514
642,289
959,309
959,309642,289645,514440,058667,793700,325691,137667,482612,465721,472758,667657,061618,6941,050,593975,8681,591,1581,546,7081,697,3791,401,7861,184,374740,240645,451461,972
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,000
200,000
200,000
180,000
0
0
0
0
0000180,000200,000200,00025,000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,000
200,000
200,000
180,000
110,000
332,406
113,519
275,102
275,102113,519332,406110,000180,000200,000200,00025,000000000000000000
       Accounts payable 
208,317
178,461
215,832
246,779
277,289
290,498
266,223
268,572
101,897
105,691
38,159
38,056
36,480
35,041
38,742
44,657
43,000
38,895
43,377
31,769
38,321
170,761
158,370
158,370170,76138,32131,76943,37738,89543,00044,65738,74235,04136,48038,05638,159105,691101,897268,572266,223290,498277,289246,779215,832178,461208,317
       Other Current Liabilities 
90,615
103,970
85,938
119,375
197,073
230,287
305,405
431,104
441,776
490,251
313,086
378,821
442,228
444,972
363,773
119,805
164,837
129,193
47,848
38,685
97,698
285,306
454,013
454,013285,30697,69838,68547,848129,193164,837119,805363,773444,972442,228378,821313,086490,251441,776431,104305,405230,287197,073119,37585,938103,97090,615
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
61,531
61,372
30,285
29,980
44,976
117,779
161,888
161,888117,77944,97629,98030,28561,37261,5310000000000000000
       Other Liabilities 
0
1,571
0
0
0
107,210
107,064
0
13,300
21,300
21,000
21,000
21,600
22,000
50,691
25,337
37,531
78,082
30,285
29,980
24,954
96,888
79,408
79,40896,88824,95429,98030,28578,08237,53125,33750,69122,00021,60021,00021,00021,30013,3000107,064107,2100001,5710
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,474
29,617
23,379
24,624
37,061
36,042
67,422
89,701
89,70167,42236,04237,06124,62423,37929,6172,474000000000000000
> Total Stockholder Equity
551,465
620,447
706,729
730,634
540,043
0
0
0
1,263
3,570
156,783
197,490
230,063
300,344
422,893
500,456
554,352
571,955
637,731
800,222
965,316
6,325,664
6,867,524
6,867,5246,325,664965,316800,222637,731571,955554,352500,456422,893300,344230,063197,490156,7833,5701,263000540,043730,634706,729620,447551,465
   Common Stock
196,683
196,683
211,683
211,683
211,683
211,683
211,683
211,683
211,683
211,683
211,683
211,683
211,683
272,578
272,578
272,578
272,578
272,578
272,578
272,578
492,435
732,919
732,387
732,387732,919492,435272,578272,578272,578272,578272,578272,578272,578211,683211,683211,683211,683211,683211,683211,683211,683211,683211,683211,683196,683196,683
   Retained Earnings 
165,288
215,645
251,547
262,905
71,451
0
0
0
0
0
0
0
0
0
36,385
113,948
147,139
168,735
250,761
411,209
455,302
846,226
1,392,311
1,392,311846,226455,302411,209250,761168,735147,139113,94836,38500000000071,451262,905251,547215,645165,288
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
472,666
0
36
360472,66600000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,286,529
Cost of Revenue-1,086,579
Gross Profit1,199,9511,199,951
 
Operating Income (+$)
Gross Profit1,199,951
Operating Expense-1,724,379
Operating Income562,150-524,428
 
Operating Expense (+$)
Research Development85,001
Selling General Administrative423,380
Selling And Marketing Expenses-
Operating Expense1,724,379508,382
 
Net Interest Income (+$)
Interest Income63,713
Interest Expense-10,054
Other Finance Cost-3,232
Net Interest Income56,891
 
Pretax Income (+$)
Operating Income562,150
Net Interest Income56,891
Other Non-Operating Income Expenses-
Income Before Tax (EBT)633,926562,150
EBIT - interestExpense = -10,054
563,787
573,841
Interest Expense10,054
Earnings Before Interest and Taxes (EBIT)-643,979
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax633,926
Tax Provision-70,967
Net Income From Continuing Ops562,958562,958
Net Income563,787
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--56,891
 

Technical Analysis of Pacific Shuanglin Bio pharmacy Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pacific Shuanglin Bio pharmacy Co Ltd. The general trend of Pacific Shuanglin Bio pharmacy Co Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pacific Shuanglin Bio pharmacy Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pacific Shuanglin Bio pharmacy Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 30.00 < 31.25.

The bearish price targets are: 29.57 > 27.97 > 27.88.

Tweet this
Pacific Shuanglin Bio pharmacy Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pacific Shuanglin Bio pharmacy Co Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pacific Shuanglin Bio pharmacy Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pacific Shuanglin Bio pharmacy Co Ltd.

Pacific Shuanglin Bio pharmacy Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartPacific Shuanglin Bio pharmacy Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pacific Shuanglin Bio pharmacy Co Ltd. The current adx is .

Pacific Shuanglin Bio pharmacy Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pacific Shuanglin Bio pharmacy Co Ltd.

Pacific Shuanglin Bio pharmacy Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pacific Shuanglin Bio pharmacy Co Ltd.

Pacific Shuanglin Bio pharmacy Co Ltd Daily Relative Strength Index (RSI) ChartPacific Shuanglin Bio pharmacy Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pacific Shuanglin Bio pharmacy Co Ltd.

Pacific Shuanglin Bio pharmacy Co Ltd Daily Stochastic Oscillator ChartPacific Shuanglin Bio pharmacy Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pacific Shuanglin Bio pharmacy Co Ltd.

Pacific Shuanglin Bio pharmacy Co Ltd Daily Commodity Channel Index (CCI) ChartPacific Shuanglin Bio pharmacy Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pacific Shuanglin Bio pharmacy Co Ltd.

Pacific Shuanglin Bio pharmacy Co Ltd Daily Chande Momentum Oscillator (CMO) ChartPacific Shuanglin Bio pharmacy Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pacific Shuanglin Bio pharmacy Co Ltd.

Pacific Shuanglin Bio pharmacy Co Ltd Daily Williams %R ChartPacific Shuanglin Bio pharmacy Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Pacific Shuanglin Bio pharmacy Co Ltd.

Pacific Shuanglin Bio pharmacy Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pacific Shuanglin Bio pharmacy Co Ltd.

Pacific Shuanglin Bio pharmacy Co Ltd Daily Average True Range (ATR) ChartPacific Shuanglin Bio pharmacy Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pacific Shuanglin Bio pharmacy Co Ltd.

Pacific Shuanglin Bio pharmacy Co Ltd Daily On-Balance Volume (OBV) ChartPacific Shuanglin Bio pharmacy Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pacific Shuanglin Bio pharmacy Co Ltd.

Pacific Shuanglin Bio pharmacy Co Ltd Daily Money Flow Index (MFI) ChartPacific Shuanglin Bio pharmacy Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pacific Shuanglin Bio pharmacy Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Pacific Shuanglin Bio pharmacy Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pacific Shuanglin Bio pharmacy Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose30.000
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pacific Shuanglin Bio pharmacy Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Pacific Shuanglin Bio pharmacy Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pacific Shuanglin Bio pharmacy Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pacific Shuanglin Bio pharmacy Co Ltd

I send you an email if I find something interesting about Pacific Shuanglin Bio pharmacy Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Pacific Shuanglin Bio pharmacy Co Ltd.

Receive notifications about Pacific Shuanglin Bio pharmacy Co Ltd in your mailbox!